A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 8, 2008

Primary Completion Date

April 1, 2014

Study Completion Date

April 18, 2014

Conditions
NeuroblastomaMelanomaOsteosarcomaEwing Sarcoma
Interventions
BIOLOGICAL

Anti-GD2 antibody

Anti-GD2 antibody

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Evan T.J. Dunbar Neuroblastoma Foundation

OTHER

collaborator

Duke University

OTHER

collaborator

University of Wisconsin, Madison

OTHER

collaborator

University Children's Hospital Tuebingen

OTHER

collaborator

Children's Hospital Los Angeles

OTHER

lead

St. Jude Children's Research Hospital

OTHER